Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension

Authors

Catherine A. Koss (ORCID: https://orcid.org/0000-0002-7297-175X)
Jane Kabami (ORCID: https://orcid.org/0000-0002-0265-3174)
Melanie C. Bacon
John Schrom (ORCID: https://orcid.org/0000-0002-3871-4311)
Joshua Schwab (ORCID: https://orcid.org/0000-0002-9436-1805)
Laura B. Balzer (ORCID: https://orcid.org/0000-0002-3730-410X)
Elijah Kakande (ORCID: https://orcid.org/0000-0001-9532-5710)
Helen Sunday
Gabriel Chamie (ORCID: https://orcid.org/0000-0002-5860-8081)
Diane V. Havlir (ORCID: https://orcid.org/0000-0003-0761-3136)
James Ayieko (ORCID: https://orcid.org/0000-0002-0324-4006)
Moses Robert Kamya (ORCID: https://orcid.org/0000-0001-9106-4234)
Maya Petersen
Alex R. Rinehart
Janice Litunya
Nicole Sutter

Institutions

National Institutes of Health (US)
University of California, San Francisco (US)
University of California System (US)
Kenya Medical Research Institute (KE)
ViiV Healthcare (United Kingdom) (GB)
Infectious Diseases Research Collaboration (UG)
National Institute of Allergy and Infectious Diseases (US)
Makerere University (UG)
University of California, Berkeley (US)

Publication Details

Journal: The Lancet HIV
Published: 2024-10-09
DOI: https://doi.org/10.1016/s2352-3018(24)00235-2
Citations: 32
Primary Topic: HIV/AIDS Research and Interventions
Type: article
Field-Weighted Citation Impact: 12.45

Funders

GlaxoSmithKline
ViiV Healthcare
National Institutes of Health
National Institute of Allergy and Infectious Diseases

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension

Catherine A. Koss, Jane Kabami, Melanie C. Bacon, John Schrom et al.

Oct 9, 2024

32 citations

The Lancet HIV

HIV/AIDS Research and Interventions

12.45

article

Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension

Catherine A. Koss, Jane Kabami, Melanie C. Bacon, John Schrom, Joshua Schwab, Laura B. Balzer, Elijah Kakande, Helen Sunday, Gabriel Chamie, Diane V. Havlir, James Ayieko, Moses Robert Kamya, Maya Petersen, Alex R. Rinehart, Janice Litunya, Nicole Sutter

October 9, 2024article en

32 citations

Abstract

No abstract available for this paper.

The Lancet HIVVol. 11(11)

National Institutes of Health (US), University of California, San Francisco (US), University of California System (US), Kenya Medical Research Institute (KE), ViiV Healthcare (United Kingdom) (GB), Infectious Diseases Research Collaboration (UG), National Institute of Allergy and Infectious Diseases (US), Makerere University (UG), University of California, Berkeley (US)

GlaxoSmithKline, ViiV Healthcare, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Good health and well-being

Openalex Percentile: Top 1%

HIV/AIDS Research and Interventions

12.45

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension — Catherine A. Koss, Jane Kabami, et al. · The Lancet HIV (2024) | TGRS Research Map | TGRS